Sector
988 stories · page 37 of 50
“The investment in Brainworks demonstrates MMJ’s expertise to secure a private negotiated investment in unlisted businesses which are not generally available to Australian retail and institutional investors,” says chairman.
MGC Pharmaceuticals Ltd has been a huge winner today, up 43.59%. MXC has signed a landmark deal with an American drug distributor worth a minimum US$24 million over the next three years.
The company said it ended the period to June 30 this year with $6.4 million (m) in cash
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
The company expects to add other members to the foundational board in due course, as appropriate
The agreement was struck with Puerto Rico Science Technology and Research Trust (PRSTRT), representing Universidad Central del Caribe (UCC) and St. Jude Children’s Research Hospital (St. Jude)
The company said it has been informed by the principals that Captiva Verde intends to launch a bid to acquire the company for 7 cents per share, a 75% premium over Binovi's closing price on Friday, August 14
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
KGK has signed four new contracts with third-party clinical research and regulatory service clients and has also been formally selected to conduct the clinical trials for four other parties, the contracts of which are currently being negoti
Noble's analysts noted that the firm’s proprietary manufacturing process for making psilocybin as well as related psychedelics could increase efficacy at lower doses
The two groups will develop the platform to transmit tryptamine-based pharmaceuticals such as DMT to treat eye diseases like glaucoma, the second-leading cause of blindness in the world
It is partnering with OVR Tech to provide its INHALE Wellness Platform, which combines the benefits of mindfulness, breathwork, and meditation with the next generation of aromatherapy
The company said it will be immediately applying for FDA approval and expanding to the US market to dramatically enhance the business model of MediSure and maximizing its potential
It expects to add to its clinic network in the coming year and continue conducting clinical trials – most of which will be funded by third parties
While the impact from the coronavirus (COVID-19) pandemic did result in longer sales cycles than usual, strong momentum and interest in the company's offering resulted in revenue growth of approximately 5%
The funding will go towards studying the effectiveness of intravenous ketamine in combination with internet-based CBT to reduce suicidality in people living with depression
The company's subsidiary KGK Science has applied for a narcotics license and completed pre-qualification audits ahead of clinical trials
It has signed a lease in Knutsford, Cheshire, from where it will manufacture Spectricept and a “range of other innovative pharmaceutical and cosmetic products”
Investors are getting excited about next generation psychedelics that aim to deliver better benefits as medications for big population groups, with full patent protection
The NeuroCatch Platform is a 6-minute brain function assessment system licensed by Health Canada as a Class II medical device
